These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 28635339

  • 1. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom.
    Danese MD, Gleeson M, Griffiths RI, Catterick D, Kutikova L.
    J Med Econ; 2017 Sep; 20(9):931-937. PubMed ID: 28635339
    [Abstract] [Full Text] [Related]

  • 2. Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.
    Hallberg S, Gandra SR, Fox KM, Mesterton J, Banefelt J, Johansson G, Levin LÅ, Sobocki P.
    Eur J Health Econ; 2016 Jun; 17(5):591-601. PubMed ID: 26077550
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
    Fox KM, Wang L, Gandra SR, Quek RGW, Li L, Baser O.
    BMC Cardiovasc Disord; 2016 Jan 14; 16():13. PubMed ID: 26769473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden.
    Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LÅ, Sobocki P, Gandra SR.
    Eur J Health Econ; 2016 Dec 14; 17(9):1117-1124. PubMed ID: 26607457
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009.
    Davis-Ajami ML, Wu J, Fink JC.
    Value Health; 2014 Dec 14; 17(1):51-61. PubMed ID: 24438717
    [Abstract] [Full Text] [Related]

  • 10. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.
    Ann Pharmacother; 2011 Mar 14; 45(3):342-9. PubMed ID: 21325098
    [Abstract] [Full Text] [Related]

  • 11. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G, Zambon A, Parodi A, Merlino L, Mancia G.
    Am J Hypertens; 2012 May 14; 25(5):549-55. PubMed ID: 22278212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
    Zhao Z, Zhu Y, Fang Y, Ye W, McCollam P.
    J Med Econ; 2015 May 14; 18(9):655-65. PubMed ID: 25891183
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD, Rattinger GB, Kuznik A, Koren MJ.
    Clin Ther; 2008 May 14; 30 Pt 2():2204-16. PubMed ID: 19281915
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia.
    Punekar RS, Fox KM, Richhariya A, Fisher MD, Cziraky M, Gandra SR, Toth PP.
    Clin Cardiol; 2015 Aug 14; 38(8):483-91. PubMed ID: 26100722
    [Abstract] [Full Text] [Related]

  • 17. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan 14; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
    Heinze G, Jandeck LM, Hronsky M, Reichardt B, Baumgärtel C, Bucsics A, Müllner M, Winkelmayer WC.
    Pharmacoepidemiol Drug Saf; 2016 Jan 14; 25(1):90-9. PubMed ID: 26468002
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.